PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated.
PolyActiva completes recruitment in key Phase I glaucoma implant safety study. Six-month treatment period demonstrated.
© 2023 PolyActiva. All Rights Reserved. Caution: PolyActiva products are not for sale in the US